Stock listing
Nextcure, Inc.
Selected listing: A41AKJ · LS · EUR · DE
Nextcure, Inc. (Lang & Schwarz: A41AKJ), Health Technology. Latest release Aug 6, 2026: NextCure Provides Business Update and Reports Second Quarter 2026…
- Ticker
- Lang & Schwarz: A41AKJ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Nextcure, Inc.
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
July 14, 2026
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
June 3, 2026
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
June 1, 2026
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Research Nextcure, Inc.
Alternate listings
NXTC:NASDAQ
US · USD
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LS.
NXTC:BOATS
US · USD
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LS.
2US0:FWB
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LS.
2US0:GETTEX
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LS.
A41AKJ:LSX
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LS.
2US0:MUN
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is A41AKJ:LS.